Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


  1. Published

    Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries

    Blimark, C. H., Vangsted, Annette Juul, Klausen, T. W., Gregersen, H., Szabo, A. G., Hermansen, E., Wålinder, G., Knut-Bojanowska, D., Zang, C., Turesson, I. & the Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG), T. R. E. G. W. T. N. M. S. G. (., 2022, In: European Journal of Haematology. 108, 2, p. 99-108 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    A polygenic risk score for multiple myeloma risk prediction

    Canzian, F., Piredda, C., Macauda, A., Zawirska, D., Andersen, N. F., Nagler, A., Zaucha, J. M., Mazur, G., Dumontet, C., Wątek, M., Jamroziak, K., Sainz, J., Várkonyi, J., Butrym, A., Beider, K., Abildgaard, N., Lesueur, F., Dudziński, M., Vangsted, A. J., Pelosini, M. & 20 others, Subocz, E., Petrini, M., Buda, G., Raźny, M., Gemignani, F., Marques, H., Orciuolo, E., Kadar, K., Jurczyszyn, A., Druzd-Sitek, A., Vogel, U., Andersen, V., Reis, R. M., Suska, A., Avet-Loiseau, H., Kruszewski, M., Tomczak, W., Rymko, M., Minvielle, S. & Campa, D., 2022, In: European Journal of Human Genetics. 30, 4, p. 474-479 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

    Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M. & 1 others, Gulbrandsen, N., 2022, In: European Journal of Haematology. 108, 1, p. 34-44 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?

    MacAuda, A., Clay-Gilmour, A., Hielscher, T., Hildebrandt, M. A. T., Kruszewski, M., Orlowski, R. Z., Kumar, S. K., Ziv, E., Orciuolo, E., Brown, E. E., Försti, A., Waller, R. G., MacHiela, M. J., Chanock, S. J., Camp, N. J., Rymko, M., Raźny, M., Cozen, W., Várkonyi, J., Piredda, C. & 36 others, Pelosini, M., Belachew, A. A., Subocz, E., Hemminki, K., Rybicka-Ramos, M., Giles, G. G., Milne, R. L., Hofmann, J. N., Zaucha, J. M. I., Vangsted, Annette Juul, Goldschmidt, H., Rajkumar, S. V., Tomczak, W., Sainz, J., Butrym, A., Watek, M., Iskierka-Jazdzewska, E., Buda, G., Robinson, D. P., Jurczyszyn, A., Dudzinski, M., Martinez-Lopez, J., Sinnwell, J. P., Slager, S. L., Jamroziak, K., Reis, R. M. V., Weinhold, N., Bhatti, P., Carvajal-Carmona, L. G., Zawirska, D., Norman, A. D., Mazur, G., Berndt, S. I., Campa, D., Vachon, C. M. & Canzian, F., 2022, In: Cancer Epidemiology Biomarkers and Prevention. 31, 9, p. 1863-1866

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The role of E3 ubiquitin ligase in multiple myeloma: potential for cereblon E3 ligase modulators in the treatment of relapsed/refractory disease

    Richardson, P. G., Mateos, M. V., Vangsted, Annette Juul, Ramasamy, K., Abildgaard, N., Ho, P. J., Quach, H. & Bahlis, N. J., 2022, In: Expert Review of Proteomics. 19, 4-6, p. 235-246

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy

    Szabo, A. G., Thorsen, J., Iversen, K. F., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Teodorescu, E. M., Dokhi, M., Kurt, E., Strandholdt, C. N., Andersen, M. K. & Vangsted, Annette Juul, 2022, In: American Journal of Hematology. 97, 3, p. E117-E120

    Research output: Contribution to journalLetterResearchpeer-review

ID: 9762536